RNAC
NASDAQ · Biotechnology
Cartesian Therapeutics Inc
$7.38
+0.17 (+2.36%)
Open$7.32
Previous Close$7.21
Day High$7.50
Day Low$7.10
52W High$11.00
52W Low$5.60
Volume—
Avg Volume138.7K
Market Cap222.38M
P/E Ratio—
EPS$-5.80
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+450.9% upside
Current
$7.38
$7.38
Target
$40.66
$40.66
$22.44
$40.66 avg
$45.57
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.20M | 10.91M | 132.93M |
| Net Income | -149,147,069 | -457,506,346 | 3.48M |
| Profit Margin | -4,658.6% | -4,425.7% | 2.6% |
| EBITDA | -160,756,448 | -520,513,379 | 5.52M |
| Free Cash Flow | — | — | 2.68M |
| Rev Growth | -70.7% | -70.7% | -1.8% |
| Debt/Equity | 0.28 | 0.28 | 0.86 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $263.29 | -1.12% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $423.64 | +1.32% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $151.28 | -0.61% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $526.73 | -0.18% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $750.51 | -0.23% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $254.07 | -0.51% | 41.4 | 33.44B |